Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced it has entered into an option agreement to purchase up to a 15% equity interest in LyoGenesis Plus for cash ...
The EvoLVcell stable producer cell line generation platform reportedly reduces variability and produces fewer impurities.
Transfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of goods (COGs), improve vector quality, and low batch variability. San Sebastián, Spain, May ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results